The Veteran's service connection claims for large B-cell non-Hodgkin's lymphoma, Hodgkin's disease (Hodgkin's lymphoma), and MGUS are granted due to presumed exposure to herbicide agents during service under the PACT Act.
The deciding factor: Service connection is established based on presumptive exposure to herbicide agents under the PACT Act for large B-cell non-Hodgkin's lymphoma, Hodgkin's disease (Hodgkin's lymphoma), and MGUS.
- Claimed conditions
- Large B-cell non-Hodgkin's lymphoma, Hodgkin's disease (Hodgkin's lymphoma), Monoclonal Gammopathy of Undetermined Significance (MGUS)
- How they argued it
- Presumptive (no nexus needed)
- Exposure basis
- Burn pits / airborne hazards
- Rating
- Not verified here — check the original decision
- Decision date
- August 18, 2023
- Citation
- 23046005
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 23046005.
What this means for you
A grant means the Board allowed the benefit or issue identified in this decision. Review the original order: other issues in the same appeal may have a different outcome, and this decision does not predict another claim.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Dismissed
The Veteran's appeals for PTSD and MGUS have been dismissed due to the withdrawal of his appeal before the Board.
- Whole decision: Partly granted
The Board granted an effective date of September 5, 2023, for the award of service connection for multiple myeloma and MGUS but denied a compensable evaluation for hypertension.
- Whole decision: Partly granted
The Board granted an effective date of August 10, 2022, for the award of service connection for monoclonal gammopathy of undetermined significance and remanded claims related to other conditions.
- Whole decision: Denied
The Board denied restoration of a 100% rating for multiple myeloma and MGUS from May 1, 2015, finding that the Veteran no longer had active disease or treatment related to these conditions.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.